LLY
Cash keeps flowing
Eli Lilly’s board just declared a third-quarter 2026 dividend of $1.73 per share on its common stock. That’s payable on September 10, 2026, to shareholders of record as of August 14, 2026.
Why you should care
Dividends aren’t exactly the Super Bowl of stock catalysts, but they do tell you something important: the company thinks its balance sheet can handle the check. For Lilly, that’s the kind of boring-in-a-good-way news investors like to see from a mega-cap pharma name that’s been busy with blockbuster drugs, pipeline bets, and the occasional Wall Street victory lap.
The investor angle
A quarterly dividend won’t send the stock moonwalking on its own. Still, it reinforces the idea that Lilly isn’t just a growth story — it’s also a cash-generating machine with enough confidence to keep rewarding shareholders.
Big picture: when a company can keep paying up while also funding the next round of science experiments, that’s usually a sign the money printer is doing just fine.